Skip to content ↓

Forum set to bring space down to earth

Space exploration calls for developing bold new concepts, which is just what entrepreneurial businesses need, according to the organizers of the MIT Enterprise Forum of Cambridge's broadcast event slated for Thursday, Sept. 22.

"The Power of Revolutionary Thinking: What Today's Scientists Can Teach You About Driving Innovation in Your Organization" will be broadcast live by Atlanta public television to MIT and 33 other worldwide sites from Tampa, Fla., to Tokyo. The panel begins at 7 p.m. in the Stata Center's Kirsch Auditorium. Entrance is free with an MIT ID, $30 for the public.

Panelists include Robert Cassanova, director of the NASA Institute for Advanced Concepts; Bradley Carl Edwards, development leader for the space elevator project; Penelope Boston, director of research for Complex Life Systems Research; and Dava Newman, MIT associate professor of aeronautics and astronautics.

The MIT event kicks off at 5:30 p.m. with refreshments and includes a 6:15 p.m. keynote by Joe Parrish, president of Payload Systems, which provides science and engineering services for spaceflight and terrestrial applications.

The broadcast is one of many educational programs fostered by the MIT Enterprise Forum Inc., an MIT Alumni Association department, and its 23 chapters. For more information, visit enterpriseforum.mit.edu/.

A version of this article appeared in MIT Tech Talk on September 21, 2005 (download PDF).

Related Links

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story